REFERENCES
- United States Department of Health and Human Services. Addressing the New Health Care Crisis. Washington: Office of the Assistant Secretary for Planning and Evaluation. Available at http://aspe.hhs.gov/daltcp/reports/medliab.htm. Accessed February 22, 2016.
- Jena AB, Seabury S, Lakdawalla D, et al. Malpractice risk according to physician specialty. N Engl J Med. 2011;365(7):629–636.
- Abbott RL, Weber P, Kelley B. Medical professional liability insurance and its relation to medical error and healthcare risk management for the practicing physician. Am J Ophthalmol. 2005;140:1106–1111.
- Anderson GF, Hussey PS, Frogner BK, et al. Health spending in the United States and the rest of the industrialized world. Health Aff. 2005;24(4):903–914.
- Day S, Menke AM, Abott RL. Retinopathy of prematurity malpractice claims: the Ophthalmic Mutual Insurance company experience. Arch Ophthalmol. 2009;127(6):794–798.
- Svider PF, Blake DM, Husain Q, et al. In the eyes of the law: malpractice litigation in oculoplastic surgery. Ophthal Plast Reconstr Surg. 2014;30(2):119–123.
- Kim JE, Weber P, Szabo A. Medical malpractice claims related to cataract surgery complicated by retained lens fragments (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2012;110:94–116.
- Abbott RL, Ou RJ, Bird M. Medical malpractice predictors and risk factors for ophthalmologists performing LASIK and photorefractive keratectomy surgery. Ophthalmology 2003;110:2137–2146.
- Fountain TJ. Ophthalmic malpractice and physician gender: a claims data analysis (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2014;112:38–49.
- Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663–667.
- Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004;111(3):491–500.
- Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013;131(11):1405–1412.
- Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990; 14 (5–6): 303–308.
- Ali N. A decade of clinical negligence in ophthalmology. BC Ophthalmol. 2007;7:20.
- Muthiah MN, Michaelides M, Child CS, et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91(11):1452–1455.
- Aizman A, Johnson MW, Elner SG. Treatment of acute retinal necrosis syndrome with oral antiviral medications. Ophthalmology. 2007;114(2):307–312.
- Dyer C. Ophthalmologist who tried to deflect blame on to others is struck off. BMJ. 2013;347.
- Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492–513.
- Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, et al. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 2011;118:1916–1926.
- Kraushar MF. Toward more effective risk prevention. Surv Ophthalmol. 2009;54:150–157.
- Kraushar MF. Practical and philosophical considerations of the physician–patient relationship. Ann Ophthalmol. 1987;19:83–84.